The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
Open accessAbstract
The human ovarian cell line A2780 was exposed to either cisplatin (10 microM) or 5-fluorouracil (5FUra) (5 microM) for 1 hr. Cytotoxicity was less than 14% with either agent alone. Cisplatin (10 microM) and 5FUra (5 microM) in combination for 1 hr caused a 76% reduction in cell growth. Thymidine (dThd, 10 microM), if given concomitantly with the combination of cisplatin and 5FUra, completely protected the tumor cells. A 30-min exposure to cisplatin increased the intracellular pools of 5,10-methylenetetrahydrofolate and tetrahydrofolate 2.5-fold. The capacity of intact cells to form 5-fluorodeoxyuridylate (FdUMP)-thymidylate (dTMP) synthase complex when incubated with fluorodeoxyuridine (FdUrd) was enhanced 2.5-fold when the cells were pretreated with cisplatin. These experiments demonstrate that cisplatin can increase the availability of the reduced folate necessary for tight binding of FdUMP to dTMP synthase, thus enhancing the cytotoxicity of the cisplatin and 5FUra combination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer
Rogan, A. M., Hamilton, T. C., Young, R. C., Klecker, R. W., & Ozols, R. F. (1984) · Science · doi:10.1126/science.6372095 · Cited by 396
Fluorinated Pyrimidines and Their Nucleosides
Heidelberger, C. (1975) · Antineoplastic and Immunosuppressive Agents · doi:10.1007/978-3-642-65806-8_12 · Cited by 336
Chemotherapy of ovarian cancer
Ozols, R. F. (1998) · Cancer Treatment and Research · doi:10.1007/978-1-4615-5447-9_7 · Cited by 298
The regulation of folate and methionine metabolism
Krebs, H. A., Hems, R., & Tyler, B. (1976) · Biochemical Journal · doi:10.1042/bj1580341 · Cited by 221
Houghton, J. A., Maroda, S. J., Phillips, J. O., & Houghton, P. J. (1981) · PubMed · Cited by 194
Scanlon, K. J., Safirstein, R. L., Thies, H. L., Gross, R. B., Waxman, S., & Guttenplan, J. B. (1983) · PubMed · Cited by 111
Self-citationJuckett, D. A., & Rosenberg, B. (1982) · PubMed · Cited by 40
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Webb, A., Cunningham, D., Scarffe, J. H., Harper, P., Norman, A., Joffe, J. K., Hughes, M., Mansi, J., Findlay, M., Hill, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.261 · Cited by 870
Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus
Ohtsu, A., Boku, N., Muro, K., Chin, K., Muto, M., Yoshida, S., Satake, M., Ishikura, S., Ogino, T., Miyata, Y., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2915 · Cited by 437
Lévi, F., Misset, J.-L., Brienza, S., Adam, R., Metzger, G., Itzakhi, M., Caussanel, J.-P., Kunstlinger, F., Lecouturier, S., Descorps-Declère, A., et al. (1992) · Cancer · doi:10.1002/1097-0142(19920215)69:4<893::aid-cncr2820690410>3.0.co;2-x · Cited by 343
Etienne, M. C., Chéradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renée, N., Schneider, M., Thyss, A., Demard, F., & Milano, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1663 · Cited by 281
Findlay, M., Cunningham, D., Norman, A., Mansi, J., Nicolson, M., Hickish, T., Nicolson, V., Nash, A., Sacks, N., Ford, H., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058932 · Cited by 257
Metadata
- Authors
- Scanlon, K. J., Newman, E. M., Lu, Y., & Priest, D. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-12
- Volume
- 83
- Issue
- 23
- Pages
- 8923-8925
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2036409540
- Cited by
- 367
- References
- 9
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.